Wednesday, July 8, 2026

Drug profile · INN

sodium nitrite

sodium nitrite (NITHIODOTE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous, intravenous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 1
Pipeline programs 0
News articles 0
Drug details — sodium nitrite
US status
approved
Class
Route
INTRAVENOUS, INTRAVENOUS
Patents
1
Programs
0
Data quality
0.84

Quick answer

sodium nitrite (NITHIODOTE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous, intravenous. Current US regulatory status: approved.

Key facts

INN sodium nitrite
Brand NITHIODOTE
Route INTRAVENOUS, INTRAVENOUS
Formulation SOLUTION

Approval history

Authority Status Date
FDA approved

Related patents

  1. US 10272039

    Topical sodium nitrite formulation

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is sodium nitrite?

sodium nitrite (NITHIODOTE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous, intravenous. Current US regulatory status: approved.

What is the brand name for sodium nitrite?

NITHIODOTE is a marketed brand name for sodium nitrite. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium nitrite?

sodium nitrite has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.